Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)

Background Sarcopenia or degenerative loss of skeletal muscle mass is related to poor prognosis in patients with cancer. This study aimed to clarify the clinical significance of skeletal muscle loss (SML) during chemotherapy for metastatic colorectal cancer (mCRC). Methods A total of 249 patients wh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical oncology 2019-10, Vol.24 (10), p.1204-1213
Hauptverfasser:	Sasaki, Shun, Oki, Eiji, Saeki, Hiroshi, Shimose, Takayuki, Sakamoto, Sanae, Hu, Qingjiang, Kudo, Kensuke, Tsuda, Yasuo, Nakashima, Yuichiro, Ando, Koji, Akagi, Yoshito, Kakeji, Yoshihiro, Baba, Hideo, Maehara, Yoshihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Body mass index Cancer Research Chemotherapy Clinical trials Colorectal cancer Colorectal carcinoma Computed tomography Medical prognosis Medicine Medicine & Public Health Metastases Musculoskeletal system Oncology Patients Prognosis Sarcopenia Skeletal muscle Surgical Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!